FRA:MSN • US5717481023
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MARSH & MCLENNAN COS (MSN.DE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-08-16 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-07-28 | Raymond James | Downgrade | Market Perform -> Underperform |
| 2021-07-23 | RBC Capital | Maintains | Outperform |
| 2021-07-23 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2021-07-09 | UBS | Maintains | Buy |
| 2021-07-09 | Wells Fargo | Maintains | Equal-Weight |
| 2021-05-27 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-04-29 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2021-04-28 | RBC Capital | Maintains | Outperform |
| 2021-04-28 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2021-04-16 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-04-15 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2021-03-24 | Morgan Stanley | Maintains | Equal-Weight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 22.736B 9.73% | 24.458B 7.57% | 26.981B 10.32% | 28.867B 6.99% | 30.35B 5.14% | 31.919B 5.17% | 31.832B -0.27% | 32.893B 3.33% | |
| EBITDA YoY % growth | 6.296B 16.03% | 6.958B 10.51% | 7.637B 9.76% | 8.362B 9.49% | 8.925B 6.73% | 9.364B 4.92% | 9.381B 0.18% | 9.649B 2.86% | |
| EBIT YoY % growth | 5.583B 18.61% | 6.212B 11.27% | 6.727B 8.29% | 6.602B -1.86% | 7.105B 7.62% | 7.362B 3.62% | N/A | N/A | |
| Operating Margin | 24.56% | 25.40% | 24.93% | 22.87% | 23.41% | 23.06% | N/A | N/A | |
| EPS YoY % growth | 7.88 15.20% | 8.80 11.68% | 9.75 10.80% | 10.60 8.68% | 11.56 9.14% | 12.49 8.04% | 13.83 10.70% | 14.83 7.23% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.31 8.25% | 3.02 11.11% | 2.00 7.95% | 2.21 4.37% | 3.57 7.85% | 3.26 7.92% | 2.20 10.25% | 2.44 10.12% | 3.82 6.98% | 3.47 6.46% | 2.36 7.10% |
| Revenue Q2Q % growth | 7.574B 7.27% | 7.464B 7.03% | 6.786B 6.85% | 7.025B 6.52% | 7.948B 4.94% | 7.833B 4.94% | 7.15B 5.36% | 7.428B 5.74% | 8.383B 5.47% | 8.196B 4.63% | 7.53B 5.31% |
| EBITDA Q2Q % growth | 2.573B 9.86% | 2.379B 0.68% | 1.72B -13.09% | 1.854B -20.05% | 2.724B 5.87% | 2.523B 6.05% | 1.835B 6.69% | 1.959B 5.66% | 2.866B 5.21% | 2.618B 3.77% | 1.888B 2.89% |
| EBIT Q2Q % growth | 2.219B 4.92% | 2.037B 6.93% | 1.511B 16.50% | 1.661B 17.89% | 2.541B 14.51% | 2.349B 15.32% | 1.661B 9.93% | 1.803B 8.55% | N/A | N/A | N/A |
All data in USD
30 analysts have analysed MSN.DE and the average price target is 184.1 EUR. This implies a price increase of 14.99% is expected in the next year compared to the current price of 160.1.
MARSH & MCLENNAN COS (MSN.DE) will report earnings on 2026-04-15, before the market open.
The consensus EPS estimate for the next earnings of MARSH & MCLENNAN COS (MSN.DE) is 3.31 EUR and the consensus revenue estimate is 7.57B EUR.
The number of analysts covering MARSH & MCLENNAN COS (MSN.DE) is 30.